142
X.-G. Liu, W. Sun / Inorganica Chimica Acta 388 (2012) 140–147
50% aqueous NaOH. 1-Bromohexadecane (22 mmol, 6.71 g) was
then added in the solution. The reaction mixture was stirred at
50 °C under argon for 18 h; and was then diluted with ethyl ace-
tate. The organic layer was washed with dilute HCl twice and brine
twice, and was dried over anhydrous Na2SO4. The resultant oil was
purified by flash chromatography (silica gel) with hexane used as
the eluent. 1H NMR (400 MHz, CDCl3): d 0.85 (t, J = 7.2 Hz, 6H,
CH3), 1.01–1.29 (m, 56H, CH2), 1.81–1.93 (m, 4H, CH2), 7.28–7.31
(m, 3H, Ar), 7.41 (d, J = 8.4 Hz, 1H, Ar), 7.60–7.64 (m, 3H, Ar).
J = 8.8 Hz, 2H), 7.54 (d, J = 8.4 Hz, 2H), 7.94–7.96 (m, 2H), 8.22 (d,
J = 8.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): d 14.1, 22.7, 23.8,
26.9, 29.2, 29.3, 29.53, 29.59, 29.6, 29.9, 31.9, 40.1, 55.5, 88.3,
95.6, 120.0, 120.8, 121.6, 122.4, 123.7, 126.4, 128.3, 130.2, 131.2,
132.2, 136.4, 141.0, 144.9, 147.0, 151.5, 152.2, 197.9. ESI-MS: m/z
calcd for C55H79NO3 [M+2H+], 803.6211; found, 803.5492.
3d. 370 mg yellow solid, yield: 94%. 1H NMR (400 MHz, CDCl3):
d 0.56–0.61 (m, 4H, CH2), 0.87 (t, J = 6.8 Hz, 6H, CH3), 1.02–1.30 (m,
52H, CH2), 1.97–2.04 (m, 4H, CH2), 2.66 (s, 3H, CH3), 3.83 (s, 3H,
OCH3), 6.87–6.91 (m, 2H, Ar), 7.49–7.53 (m, 4H, Ar), 7.70–7.74
(m, 2H, Ar), 7.94–7.96 (m, 2H, Ar). 13C NMR (100 MHz, CDCl3): d
14.1, 22.7, 23.7, 26.8, 29.2, 29.3, 29.52, 29.57, 29.6, 29.9, 31.9,
40.2, 55.2, 55.4, 88.9, 90.2, 114.0, 115.3, 119.7, 120.6, 122.4,
123.3, 125.9, 128.2, 130.6, 133.0, 136.0, 139.6, 145.3, 151.3,
152.0, 159.7, 197.9. ESI-MS: m/z calcd for C56H82O2 [M+Na+],
809.6213; found, 809.6186.
2.1.2.3. Dihexadecyl-7-iodo-9H-fluoren-2-yl)ethanone (1) [14]. Acetyl
chloride (224 ll, 3.15 mmol, 247 mg) was slowly added at 0 °C to a
suspension of anhydrous AlCl3 (3.60 mmol, 480 mg) in dry CH2Cl2
(10 ml). A CH2Cl2 solution of 9,9-dihexadecyl-2-iodo-9H-fluorene
(3.00 mmol, 2.22 g) was added dropwise and the mixture was stir-
red at room temperature for 18 h. The reaction mixture was poured
onto ice and a concentrated HCl aqueous solution was added until
the precipitate of Al(OH)3 dissolved. The organic layer was sepa-
rated and the aqueous phase was extracted twice with CH2Cl2.
The organic phases were combined, washed with water, 2% NaOH
solution, water, brine, and dried over Na2SO4. After evaporation of
the solvent, the oil obtained was purified by flash chromatography
(silica gel, with hexane to hexane/ethyl acetate = 75:1–30:1–15:1
used as the eluent). 1.80 g white solid was obtained (yield = 77%).
1H NMR (400 MHz, CDCl3): d 0.52–0.54 (m, 4H, CH2), 0.84 (t,
J = 6.4 Hz, 6H, CH3), 0.86–1.27 (m, 52H, CH2), 1.89–1.98 (m, 4H,
CH2), 2.63 (s, 3H, CH3), 7.45–7.48 (m, 1H, Ar), 7.65–7.71 (m, 3H,
Ar), 7.90–7.93 (m, 2H, Ar). 13C NMR (100 MHz, CDCl3): d 14.1,
22.7, 23.7, 26.8, 29.2, 29.3, 29.5, 29.57, 29.63, 29.8, 31.9, 40.0,
55.5, 94.3, 119.6, 122.2, 122.4, 128.2, 132.3, 136.1, 136.3, 139.4,
144.9, 150.5, 154.2, 197.8.
2.1.4. Synthesis of ligands 4a–4d
2.1.4.1. Typical procedure for Friedländer condensation [15]. A mix-
ture of 8-aminoquinoline-7-carbaldehyde (1.0 equiv.), 3 (1.1 equiv.)
and KOH (2.5 equiv.) in absolute EtOH was refluxed for 18–24 h
under argon and cooled to room temperature. The solvent was
evaporated under vacuum and the residue was extracted with
ethyl acetate. The organic phase was washed with water for three
times and dried over anhydrous Na2SO4. After removal of the sol-
vent, the residue was purified by column chromatography (neutral
Al2O3 gel) with hexane/ethyl acetate used as the eluent.
Ligand 4a: 266 mg yellow oil, yield: 78%. 1H NMR (400 MHz,
CDCl3): d 0.67–0.70 (m, 4H, CH2), 0.86 (t, J = 6.8 Hz, 6H, CH3),
1.05–1.29 (m, 52H, CH2), 2.02–2.16 (m, 4H, CH2), 7.32–7.38 (m,
3H, Ar), 7.55–7.60 (m, 4H, Ar), 7.61–7.64 (dd, J1 = 4.4 Hz,
J2 = 8.0 Hz, 1H, Ar), 7.74–7.82 (m, 3H, Ar), 7.87 (d, J = 8.0 Hz, 1H,
Ar), 8.13–8.16 (m, 2H, Ar), 8.24 (dd, J1 = 1.6 Hz, J2 = 8.0 Hz, 1H,
Ar), 8.30 (dd, J1 = 4.4 Hz, J2 = 8.4 Hz, 1H, Ar), 8.45 (dd, J1 = 1.6 Hz,
J2 = 8.0 Hz, 1H, Ar), 9.25 (dd, J1 = 1.6 Hz, J2 = 4.0 Hz, 1H, Ar). 13C
NMR (100 MHz, CDCl3): d 14.1, 22.7, 23.8, 29.3, 29.56, 29.59,
29.6, 30.0, 31.9, 40.5, 55.4, 89.5, 09.6, 120.1, 120.5, 121.1, 121.7,
121.9, 122.9, 123.5, 126.0, 126.2, 126.4, 127.5, 127.8, 128.1,
128.3, 129.1, 130.7, 131.6, 136.0, 136.7, 139.3, 141.0, 141.7,
146.2, 146.4, 150.4, 151.4, 151.5, 158.1. ESI-MS: m/z calcd for
2.1.3. Synthesis of 3 using Sonogashira cross-coupling reaction
2.1.3.1. General procedure for Sonogashira cross-coupling reac-
tion. Compounds
1
(1.0 equiv.),
2
(1.0 equiv.), Pd(PPh3)Cl2
(0.10 equiv.), PPh3 (0.20 equiv.), and CuI (0.20 equiv.) were added
to a round-bottom flask. The flask was evacuated and backfilled
with argon. Et3N (15 ml) was then added. The reaction mixture
was heated at reflux for 24 h; and then was allowed to cool down
to room temperature. After removal of the solvent, the residue was
extracted with CH2Cl2, and the CH2Cl2 layer was washed with
water and brine and dried over anhydrous Na2SO4. The solvent
was then removed and the crude product was purified by column
chromatography (silica gel) with hexane/ethyl acetate used as
eluent.
C
C
65H84N2 [M+H+], 893.6713; found, 893.6718. Anal. Calc. for
65H84N2 + H2O: C, 85.66; H, 9.51; N, 3.07. Found: C, 85.72; H,
9.10; N, 3.17%.
Ligand 4b: 238 mg yellow solid, yield: 78%. 1H NMR (400 MHz,
CDCl3): d 0.67–0.70 (m, 4H, CH2), 0.86 (t, J = 6.4 Hz, 6H, CH3),
1.05–1.27 (m, 52H, CH2), 2.05–2.17 (m, 4H, CH2), 7.42–7.44 (m,
2H, Ar), 7.48–7.51 (m, 2H, Ar), 7.53–7.55 (m, 2H, Ar), 7.64 (dd,
J1 = 4.4 Hz, J2 = 8.0 Hz, 1H, Ar), 7.74–7.83 (m, 3H, Ar), 7.87 (d,
J = 8.0 Hz, 1H, Ar), 8.14–8.16 (m, 2H, Ar), 8.25 (d, J = 8.0 Hz, 1H,
Ar), 8.32 (d, J = 8.4 Hz, 1H, Ar), 8.46 (d, J = 8.0 Hz, 1H, Ar), 9.25–
9.26 (m, 1H, Ar). 13C NMR (100 MHz, CDCl3): d 14.1, 22.6, 23.8,
29.3, 29.5, 29.6, 30.0, 31.9, 40.4, 55.4, 88.5, 91.8, 120.1, 120.5,
121.1, 121.3, 121.9, 122.3, 122.4, 122.9, 125.9, 126.2, 126.3,
127.4, 127.8, 129.0, 130.7, 131.6, 132.9, 136.0, 136.7, 139.4,
141.3, 141.6, 146.2, 146.4, 150.4, 151.4, 151.5, 158.0. ESI-MS: m/z
calcd for C65H83Br79N2 [M+H+], 971.5818; found, 971.6057. Anal.
Calc. for C65H83BrN2: C, 80.30; H, 8.60; N, 2.88. Found: C, 80.13;
H, 8.38; N, 2.86%.
3a. 320 mg yellow solid, yield: 85%. 1H NMR (400 MHz, CDCl3):
d 0.55–0.57 (m, 4H, CH2), 0.85 (t, J = 6.0 Hz, 6H, CH3), 1.01–1.27 (m,
52H, CH2), 1.93–2.05 (m, 4H, CH2), 2.64 (s, 3H, CH3), 7.32–7.34 (m,
3H, Ar), 7.52–7.56 (m, 4H, Ar), 7.71 (t, J = 6.8 Hz, 2H, Ar), 7.93–7.95
(m, 2H, Ar). 13C NMR (100 MHz, CDCl3): d 14.1, 22.7, 23.7, 26.8,
29.2, 29.3, 29.52, 29.57, 29.6, 29.9, 31.9, 40.2, 55.4, 90.2, 119.7,
120.6, 122.4, 123.0, 123.2, 126.1, 128.2, 128.3, 128.34, 130.8,
131.6, 136.1, 139.9, 145.2, 151.3, 152.0, 197.9. ESI-MS: m/z calcd
for C55H80O [M+Na+], 779.6107; found, 779.6094.
3b. 370 mg yellow solid, yield: 86%. 1H NMR (400 MHz, CDCl3):
d 0.56–0.58 (m, 4H, CH2), 0.87 (t, J = 6.8 Hz, 6H, CH3), 1.02–1.28 (m,
52H, CH2), 1.94–2.05 (m, 4H, CH2), 2.66 (s, 3H, CH3), 7.40–7.43 (m,
2H, Ar), 7.47–7.54 (m, 4H, Ar), 7.71–7.75 (m, 2H, Ar), 7.94–7.97 (m,
2H, Ar). 13C NMR (100 MHz, CDCl3): d 14.1, 22.7, 23.7, 26.8, 29.2,
29.3, 29.5, 29.58, 29.63, 29.9, 31.9, 40.1, 55.4, 89.1, 91.3, 119.8,
120.7, 122.2, 122.4, 122.6, 126.1, 128.2, 130.8, 131.7, 133.0,
136.2, 140.2 145.1, 151.3, 152.1, 197.9. ESI-MS: m/z calcd for
Ligand 4c: 186 mg yellow solid, yield: 60%. 1H NMR (400 MHz,
CDCl3): d 0.65–0.67 (m, 4H, CH2), 0.82 (t, J = 6.8 Hz, 6H, CH3),
1.02–1.23 (m, 52H, CH2), 2.01–2.17 (m, 4H, CH2), 7.53–7.55 (m,
2H, Ar), 7.60 (dd, J1 = 4.0 Hz, J2 = 8.0 Hz, 1H, Ar), 7.65 (d,
J = 8.8 Hz, 2H, Ar), 7.71–7.78 (m, 3H, Ar), 7.86 (d, J = 8.0 Hz, 1H,
Ar), 8.12 (d, J = 8.4 Hz, 1H, Ar), 8.17–8.29 (m, 4H, Ar), 8.28 (d,
J = 8.4 Hz, 1H, Ar), 8.42 (d, J = 8.4 Hz, 1H, Ar), 9.20–9.21 (m, 1H).
13C NMR (100 MHz, CDCl3): d 14.0, 22.6, 23.8, 29.2, 29.5, 29.6,
C
55H79OBr81 [M+Na+], 859.5368; found, 859.6055.
3c. 290 mg yellow solid, yield: 72%. 1H NMR (500 MHz, CDCl3):
d 0.54–0.55 (m, 4H), 0.82–0.86 (t, J = 6.4 Hz, 6H), 1.00–1.23 (m,
52H), 1.96–2.02 (m, 4H), 2.65 (s, 3H), 7.53–7.56 (m, 2H), 7.68 (d,